Cofounded by CRISPR pioneer Jennifer Doudna at the University of California, Berkeley, the company has long sought to downsize the original CRISPR-Cas9 system. Their new iteration, dubbed NanoCas, ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

Building a gene editor took months. With CRISPR even high-schoolers can get hold of editing systems in the time it takes to order RNA sequences online and have them shipped by FedEx. In a short while ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Scribe – which counts new Nobel Prize for chemistry winner Jennifer Doudna among its founders ... It will also use a variation of CRISPR/Cas9 known as CRISPR/Casx which is smaller, making ...

chemistry laureate Jennifer Doudna In her 2020 Nobel Prize lecture, Doudna spoke about all the new opportunities created by the development of the gene-editing tool CRISPR-Cas9. In March last year ...

The possibilities are endless.” – chemistry laureate Jennifer Doudna In her 2020 Nobel Prize lecture, Doudna spoke about all the new opportunities created by the development of the gene-editing tool ...

a novel Cas enzyme approximately one third the size of Cas9 ? which can be easily accommodated ... life-threatening and debilitating diseases. Founded by CRISPR pioneer and Nobel laureate Jennifer ...